000 01833 a2200493 4500
005 20250517081620.0
264 0 _c20161226
008 201612s 0 0 eng d
022 _a1875-5739
024 7 _a10.2174/1567202613666160219115832
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRéus, Gislaine Zilli
245 0 0 _aAntioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitus.
_h[electronic resource]
260 _bCurrent neurovascular research
_c2016
300 _a107-14 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetylcysteine
_xpharmacology
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aBrain
_xdrug effects
650 0 4 _aBrain-Derived Neurotrophic Factor
_xmetabolism
650 0 4 _aDeferoxamine
_xpharmacology
650 0 4 _aDiabetes Mellitus, Experimental
_xdrug therapy
650 0 4 _aMAP Kinase Kinase 4
_xmetabolism
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _ap38 Mitogen-Activated Protein Kinases
_xmetabolism
700 1 _aBernardini Dos Santos, Maria Augusta
700 1 _aAbelaira, Helena Mendes
700 1 _aMaciel, Amanda Luis
700 1 _aArent, Camila Orlandi
700 1 _aMatias, Beatriz Iladi
700 1 _aBruchchen, Lívia
700 1 _aIgnácio, Zuleide Maria
700 1 _aMichels, Monique
700 1 _aDal-Pizzol, Felipe
700 1 _aCarvalho, André Ferrer
700 1 _aZugno, Alexandra Ioppi
700 1 _aQuevedo, João
773 0 _tCurrent neurovascular research
_gvol. 13
_gno. 2
_gp. 107-14
856 4 0 _uhttps://doi.org/10.2174/1567202613666160219115832
_zAvailable from publisher's website
999 _c25747070
_d25747070